找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Histone Deacetylase Inhibitors — Epidrugs for Neurological Disorders; Shabir Ahmad Ganai Book 2019 Springer Nature Singapore Pte Ltd. 2019

[復(fù)制鏈接]
樓主: Radiofrequency
21#
發(fā)表于 2025-3-25 05:06:59 | 只看該作者
Epigenetics and its Implications in Neurological Disorders,tions of histone and non-histone substrates. Epigenetic dysregulation due to aberrant activity of these players alters homeostasis provoking neurological complications. Here I discuss the amendments of the definition of epigenetics over time and the various post-translational modifications that hist
22#
發(fā)表于 2025-3-25 09:23:09 | 只看該作者
Epigenetic Enzymes and Drawbacks of Conventional Therapeutic Regimens, acetylation, methylation, phosphorylation etc. Methylation of DNA cytosine is also regarded as epigenetic modifications as it causes gene repression by recruiting HDACs. This chapter gives the bird’s eye view of writers and erasers of epigenetic modifications. Among the writers, special emphasis ha
23#
發(fā)表于 2025-3-25 15:12:22 | 只看該作者
24#
發(fā)表于 2025-3-25 19:15:31 | 只看該作者
25#
發(fā)表于 2025-3-25 22:42:41 | 只看該作者
HDAC Inhibitors as Novel Therapeutic Option Against Therapeutically Challenging Neurological Disordulation and as such are emerging as promising therapeutic agents for vanquishing neurological disorders. Here we discuss the marvellous therapeutic effect of various HDACi against neurological disorders including Alzheimer’s disease, Parkinson’s disease, and epilepsy. The underlying molecular player
26#
發(fā)表于 2025-3-26 02:27:31 | 只看該作者
27#
發(fā)表于 2025-3-26 07:28:35 | 只看該作者
28#
發(fā)表于 2025-3-26 09:05:44 | 只看該作者
29#
發(fā)表于 2025-3-26 16:36:01 | 只看該作者
Future Directions, a particular neurological complication, neuronal death or damage is not general, but specific brain regions are particularly affected. Different focal pathologies are exhibited by distinct disorders, and thus gaining insights regarding the region-specific effects of these inhibitors is requisite fo
30#
發(fā)表于 2025-3-26 17:05:27 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 08:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
盐山县| 垫江县| 桂平市| 丘北县| 宣汉县| 怀远县| 西丰县| 商洛市| 东阳市| 察哈| 襄樊市| 普陀区| 宜州市| 东海县| 盐亭县| 新绛县| 社旗县| 万山特区| 永新县| 三原县| 安徽省| 蒙城县| 清镇市| 玉屏| 巴彦淖尔市| 土默特右旗| 开封市| 嘉鱼县| 安阳县| 通州市| 临安市| 宜都市| 岳阳市| 喀喇沁旗| 铜鼓县| 通州区| 鲁山县| 北辰区| 花垣县| 商洛市| 于都县|